GE HealthCare has introduced Revolution RT, a radiation therapy computed tomography (CT) solution designed to boost imaging accuracy.
It is also claimed to simplify the simulation workflow to provide more personalised and seamless oncology care for clinicians and patients.
Featuring a wide-bore CT platform, Revolution RT is claimed to provide high-performance radiation therapy simulation, diagnostic, and interventional capabilities to accommodate more patients.
Using deep learning technology, the new system helps image the patient with accuracy.
This technology was showcased at the European Society for Therapeutic Radiology and Oncology 2024 Congress (ESTRO) in Glasgow, Scotland.
Alongside Revolution RT, GE HealthCare also introduced an updated version of the Intelligent Radiation Therapy Platform (iRT), now augmented with AI.
Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Company Profile – free
sample
Your download email will arrive shortly
We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form
By GlobalData
The iRT platform, which interfaces with the Spectronic magnetic resonance imaging Planner, was originally launched at ESTRO 2023.
Besides claiming to enable greater interoperability, connectivity, and efficiency throughout the radiation oncology care continuum, it offers features such as an integrated workflow that links many applications into an intuitive single interface, multi-vendor interoperability, seamless data transfer and task automation, and a catalogue of RT applications from both the company as well as third parties.
GE HealthCare chief technology and science officer Dr Taha Kass-Hout said: “At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimise the care continuum.
“Our showcase at ESTRO this year highlights innovations that will allow clinicians to view the patient’s anatomy with great accuracy, helping facilitate precise tumour targeting while aiming to protect nearby healthy tissue.
“By integrating these capabilities into our systems, we create a precise, more connected, and efficient care environment that accelerates the delivery of personalised care, with the goal of enabling better patient outcomes.
“This comprehensive approach empowers clinicians around the globe to tackle the most challenging disease states with precision and efficiency.”
